...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: possible catalyst(s)??

ZENITH P​ERFORMANCE

5 Day
  • -33.33%
1 Month
  • -68.00%
3 Month
  • -66.67%
YTD
  • -82.22%
1 Year
  • -80.49%

Is this the sort of Performance we're looking at until 2028? Is this what shareholders expected after 8 years? Is this the sort of share value a good CEO would achieve​ in this time frame​ or is this something you would see from a CEO that's got his head stuck in sand​ while​ playing in his Hawwian sandbox the majority of the time?

Last time he spoke "a whirlwind" of activity/things happening"over the last 9 months.Really Don, isn't that​ just​ wonderful & so exciting for all us shareholders.Give us a freaking break with your excitement & hard work talk, proofs in the pudding there fella. 

​P​lease tell us what you've done & what you're going to do for us shareholders? So far you are the only one that's put money in your pocket, how can we be excited for your good fortune while you let us hang out to dry?

 Don't blame the expert market,you can make the changes needed to allow us to see some value & liquidity.

 It's well past time.

Share
New Message
Please login to post a reply